权衡西方早期胃癌内镜黏膜下剥离术的利弊。 - Suppr

Suppr

超能文献

Outweighing the benefits and weakness of endoscopic submucosal dissection for early gastric cancer in the west.

作者信息

Spiliotis J, Ziogas D, Baltogiannis G

出版信息

Surg Endosc. 2010 Jun;24(6):1507-9. doi: 10.1007/s00464-009-0789-4.

DOI:10.1007/s00464-009-0789-4

PMID:20044771

Abstract

摘要

相似文献

Outweighing the benefits and weakness of endoscopic submucosal dissection for early gastric cancer in the west.

Surg Endosc. 2010 Jun;24(6):1507-9. doi: 10.1007/s00464-009-0789-4.

Endoscopic submucosal dissection for early gastric cancer: is it the best option for patients with contraindications to surgery?

Gastrointest Endosc. 2010 Aug;72(2):464; author reply 464-5. doi: 10.1016/j.gie.2009.11.007.

Endoscopic submucosal dissection-bigger piece, better outcome!

Gastrointest Endosc. 2006 Dec;64(6):884-5. doi: 10.1016/j.gie.2006.06.012. Epub 2006 Sep 20.

Endoscopic submucosal dissection for early gastric cancer: quo vadis?

World J Gastroenterol. 2011 Jun 7;17(21):2623-5. doi: 10.3748/wjg.v17.i21.2623.

Worldwide experiences of endoscopic submucosal dissection: not just Eastern acrobatics.

World J Gastroenterol. 2011 Jun 7;17(21):2611-7. doi: 10.3748/wjg.v17.i21.2611.

Curability risks by endoscopic submucosal dissection for early gastric cancer.

Surg Endosc. 2010 May;24(5):1224-5. doi: 10.1007/s00464-009-0749-z.

Expanding indications for ESD: mucosal disease (upper and lower gastrointestinal tract).

Gastrointest Endosc Clin N Am. 2014 Apr;24(2):161-7. doi: 10.1016/j.giec.2013.12.002.

Gastric adenocarcinoma with a submucosal cyst treated by endoscopic submucosal dissection (ESD).

Endoscopy. 2009;41 Suppl 2:E267-8. doi: 10.1055/s-0029-1215203. Epub 2009 Oct 28.

The international emergence of endoscopic submucosal dissection for early gastric cancer.

Gastrointest Endosc. 2011 May;73(5):928-31. doi: 10.1016/j.gie.2011.01.016.

Do you have what it takes for challenging endoscopic submucosal dissection cases?

World J Gastroenterol. 2011 Aug 21;17(31):3580-4. doi: 10.3748/wjg.v17.i31.3580.

引用本文的文献

Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry.

United European Gastroenterol J. 2021 Jul;9(6):718-726. doi: 10.1002/ueg2.12101. Epub 2021 Jun 2.

Recent developments and innovations in gastric cancer.

World J Gastroenterol. 2016 May 7;22(17):4307-20. doi: 10.3748/wjg.v22.i17.4307.

本文引用的文献

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69.

Isolated tumor cells in breast cancer.

N Engl J Med. 2009 Nov 12;361(20):1994-5; author reply 1995-6.

Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Ann Surg Oncol. 2010 Jan;17(1):14-7. doi: 10.1245/s10434-009-0766-0. Epub 2009 Oct 20.

Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Expert Rev Anticancer Ther. 2009 Oct;9(10):1413-6. doi: 10.1586/era.09.116.

CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer?

Ann Surg Oncol. 2009 Oct;16(10):2678-81. doi: 10.1245/s10434-009-0598-y. Epub 2009 Jul 28.

Clinical outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer.

Surg Endosc. 2010 Mar;24(3):509-16. doi: 10.1007/s00464-009-0614-0. Epub 2009 Jul 8.

Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology.

Ann Surg. 2009 Jun;249(6):1067-8. doi: 10.1097/SLA.0b013e3181a88b69.

Personalized cancer diagnostics and therapeutics.

Expert Rev Mol Diagn. 2009 Apr;9(3):227-9. doi: 10.1586/erm.09.6.

Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine.

Expert Rev Mol Diagn. 2009 Apr;9(3):217-21. doi: 10.1586/erm.09.7.

Genome-wide association studies: how predictable is a person's cancer risk?

Expert Rev Anticancer Ther. 2009 Apr;9(4):389-92. doi: 10.1586/era.09.12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Outweighing the benefits and weakness of endoscopic submucosal dissection for early gastric cancer in the west.

作者信息

Spiliotis J, Ziogas D, Baltogiannis G

出版信息

Surg Endosc. 2010 Jun;24(6):1507-9. doi: 10.1007/s00464-009-0789-4.

DOI:10.1007/s00464-009-0789-4

PMID:20044771

Abstract

摘要

相似文献

Outweighing the benefits and weakness of endoscopic submucosal dissection for early gastric cancer in the west.

Surg Endosc. 2010 Jun;24(6):1507-9. doi: 10.1007/s00464-009-0789-4.

Endoscopic submucosal dissection for early gastric cancer: is it the best option for patients with contraindications to surgery?

Gastrointest Endosc. 2010 Aug;72(2):464; author reply 464-5. doi: 10.1016/j.gie.2009.11.007.

Endoscopic submucosal dissection-bigger piece, better outcome!

Gastrointest Endosc. 2006 Dec;64(6):884-5. doi: 10.1016/j.gie.2006.06.012. Epub 2006 Sep 20.

Endoscopic submucosal dissection for early gastric cancer: quo vadis?

World J Gastroenterol. 2011 Jun 7;17(21):2623-5. doi: 10.3748/wjg.v17.i21.2623.

Worldwide experiences of endoscopic submucosal dissection: not just Eastern acrobatics.

World J Gastroenterol. 2011 Jun 7;17(21):2611-7. doi: 10.3748/wjg.v17.i21.2611.

Curability risks by endoscopic submucosal dissection for early gastric cancer.

Surg Endosc. 2010 May;24(5):1224-5. doi: 10.1007/s00464-009-0749-z.

Expanding indications for ESD: mucosal disease (upper and lower gastrointestinal tract).

Gastrointest Endosc Clin N Am. 2014 Apr;24(2):161-7. doi: 10.1016/j.giec.2013.12.002.

Gastric adenocarcinoma with a submucosal cyst treated by endoscopic submucosal dissection (ESD).

Endoscopy. 2009;41 Suppl 2:E267-8. doi: 10.1055/s-0029-1215203. Epub 2009 Oct 28.

The international emergence of endoscopic submucosal dissection for early gastric cancer.

Gastrointest Endosc. 2011 May;73(5):928-31. doi: 10.1016/j.gie.2011.01.016.

Do you have what it takes for challenging endoscopic submucosal dissection cases?

World J Gastroenterol. 2011 Aug 21;17(31):3580-4. doi: 10.3748/wjg.v17.i31.3580.

引用本文的文献

Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry.

United European Gastroenterol J. 2021 Jul;9(6):718-726. doi: 10.1002/ueg2.12101. Epub 2021 Jun 2.

Recent developments and innovations in gastric cancer.

World J Gastroenterol. 2016 May 7;22(17):4307-20. doi: 10.3748/wjg.v22.i17.4307.

本文引用的文献

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69.

Isolated tumor cells in breast cancer.

N Engl J Med. 2009 Nov 12;361(20):1994-5; author reply 1995-6.

Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Ann Surg Oncol. 2010 Jan;17(1):14-7. doi: 10.1245/s10434-009-0766-0. Epub 2009 Oct 20.

Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Expert Rev Anticancer Ther. 2009 Oct;9(10):1413-6. doi: 10.1586/era.09.116.

CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer?

Ann Surg Oncol. 2009 Oct;16(10):2678-81. doi: 10.1245/s10434-009-0598-y. Epub 2009 Jul 28.

Clinical outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer.

Surg Endosc. 2010 Mar;24(3):509-16. doi: 10.1007/s00464-009-0614-0. Epub 2009 Jul 8.

Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology.

Ann Surg. 2009 Jun;249(6):1067-8. doi: 10.1097/SLA.0b013e3181a88b69.

Personalized cancer diagnostics and therapeutics.

Expert Rev Mol Diagn. 2009 Apr;9(3):227-9. doi: 10.1586/erm.09.6.

Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine.

Expert Rev Mol Diagn. 2009 Apr;9(3):217-21. doi: 10.1586/erm.09.7.

Genome-wide association studies: how predictable is a person's cancer risk?

Expert Rev Anticancer Ther. 2009 Apr;9(4):389-92. doi: 10.1586/era.09.12.